Postoperative RecoveryQoR15T-CARDİACNCT07593794
QoR-15T in Cardiac Surgery
An observational study of Postoperative Recovery and Patient Reported Outcome Measures, run by Kocaeli City Hospital at 1 site in Turkey (Türkiye).
Trial summary
The objective of this prospective observational cohort study is to evaluate the validity, reliability, and responsiveness of the Turkish version of the Quality of Recovery-15 (QoR-15T) scale in adult patients undergoing elective cardiac surgery. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Postoperative Recovery, Patient Reported Outcome Measures
- How many people
- 150 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 18 May 2026to 15 Oct 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Adult, Older adult
Study population: The study population consists of adult patients (aged 18 and over) who are scheduled for elective cardiac surgery (including coronary artery bypass grafting, valve replacement or repair, and aortic surgery) at Kocaeli City Hospital.
Who may be able to join
- Adult patients aged 18 years and older.
- Patients scheduled for elective cardiac surgery (CABG, valve replacement, or aortic surgery).
- Patients capable of understanding and answering the Turkish version of the QoR-15 questionnaire.
- Patients who provide written informed consent.
Who cannot join
- Emergency surgeries or revision surgeries
- Patients with severe cognitive impairment or psychiatric disorders that prevent completion of the scale
- Patients who refuse to participate at any stage.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Mehmet Yılmaz, Ass. Prof. contact
Turkey (Türkiye)1 site, 1 recruiting
- Recruiting
Kocaeli City Hospital
Kocaeli
Zeynep Yasemin Tavşanoğlu, MD, DESAIC, +902622252700, zeynepyaseminyilmaz@gmail.com
About this study
Official title: Validity and Reliability of the Turkish Quality of Recovery-15 (QoR-15T) Scale in Cardiac Surgery Patients: A Prospective Observational Cohort Study
The objective of this prospective observational cohort study is to evaluate the validity, reliability, and responsiveness of the Turkish version of the Quality of Recovery-15 (QoR-15T) scale in adult patients undergoing elective cardiac surgery. While the QoR-15T has been validated for general surgery in Turkey, its performance remains to be established in high-risk cardiac surgery populations involving cardiopulmonary bypass and intensive care stays.Approximately 150 patients at Kocaeli City Hospital will be enrolled. The study will compare the patients' QoR-15T scores-recorded preoperatively and on the 7th postoperative day-with the Global Recovery Visual Analog Scale (VAS) to determine construct validity.
What is being measured
The primary outcome is the main question the study is designed to answer.
Postoperative Quality of Recovery Score (QoR-15T)
The Turkish version of the 15-item Quality of Recovery scale (QoR-15T). Each item is scored 0-10. Total score ranges from 0 to 150
Measured: Postoperative Day 7 (or discharge day if earlier)
Secondary outcomes (1)
Global Recovery Visual Analog Scale (VAS)
A self-reported scale where patients rate their overall recovery on a line from 0 to 100 (0 = poor recovery, 100 = excellent recovery). This will be used to assess the construct validity of the QoR-15T
Measured: Postoperative Day 7
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 May 2026
- Study start18 May 2026
- Primary completion30 Sep 2026 (estimated)
- Study completion15 Oct 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Postoperative RecoveryStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 150 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Kocaeli City Hospital
- Sponsor type
- Other government
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07593794
- Sponsor's protocol ID
- KSH_ZYT_2
- Acronym
- QoR15T-CARDİAC
- Status last verified
- Jun 2026
- First submitted
- 12 May 2026
- Last updated
- 8 Jun 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 8 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Validity and Reliability of the Turkish Quality of Recovery-15 (QoR-15T) Scale in Cardiac Surgery Patients: A Prospective Observational Cohort Study
- ClinicalTrials.gov ID
- NCT07593794
- Acronym / sponsor ID
- QoR15T-CARDİAC / KSH_ZYT_2
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 150 participants (estimated)
- Lead sponsor
- Kocaeli City HospitalOther government
- Study start
- 18 May 2026 (actual)
- Primary completion
- 30 Sep 2026 (estimated)
- Study completion
- 15 Oct 2026 (estimated)
- First posted
- 18 May 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The objective of this prospective observational cohort study is to evaluate the validity, reliability, and responsiveness of the Turkish version of the Quality of Recovery-15 (QoR-15T) scale in adult patients undergoing elective cardiac surgery. While the QoR-15T has been validated for general surgery in Turkey, its performance remains to be established in high-risk cardiac surgery populations involving cardiopulmonary bypass and intensive care stays.Approximately 150 patients at Kocaeli City Hospital will be enrolled. The study will compare the patients' QoR-15T scores-recorded preoperatively and on the 7th postoperative day-with the Global Recovery Visual Analog Scale (VAS) to determine construct validity.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- The study population consists of adult patients (aged 18 and over) who are scheduled for elective cardiac surgery (including coronary artery bypass grafting, valve replacement or repair, and aortic surgery) at Kocaeli City Hospital.
Key inclusion criteria (4 listed)
- Adult patients aged 18 years and older.
- Patients scheduled for elective cardiac surgery (CABG, valve replacement, or aortic surgery).
- Patients capable of understanding and answering the Turkish version of the QoR-15 questionnaire.
- Patients who provide written informed consent.
Key exclusion criteria (3 listed)
- Emergency surgeries or revision surgeries
- Patients with severe cognitive impairment or psychiatric disorders that prevent completion of the scale
- Patients who refuse to participate at any stage.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Postoperative Quality of Recovery Score (QoR-15T)
Time frame: Postoperative Day 7 (or discharge day if earlier)
The Turkish version of the 15-item Quality of Recovery scale (QoR-15T). Each item is scored 0-10. Total score ranges from 0 to 150
1 secondary outcome
Global Recovery Visual Analog Scale (VAS)
Time frame: Postoperative Day 7
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Jun 2026.
Related trials for Postoperative Recovery
Not yet recruiting
The Contribution of Accelerated Recovery (mERAS) Approach to Postoperative Recovery in Pediatric Laparoscopic Surgery Cases
mERAS Intervention, The ASA (American Society of Anesthesiologists) Score
Active, not recruiting
Pivotal Study on the NOVABLOC System for Patients Undergoing Primary Total Knee Arthroplasty
Pain
Not yet recruiting
Opioid Reduction and Enhanced Recovery in Orthopaedic Surgery (OREOS)-Knee
Knee Arthroplasty, Total, Partial Knee Arthroplasty
Recruiting
Resistance vs Aerobic Prehabilitation Before Colorectal Cancer Surgery
Colorectal Cancer, Colorectal Neoplasms
Enrolling by invitation
Long-term Follow-up of Bio-signals and Quality of Recovery Following Implementation of ERAS Based on the Mobile Application
Gynecologic Surgery, General Anesthesia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Mehmet Yılmaz, Ass. Prof. contact
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Postoperative Recovery and Patient Reported Outcome Measures, run by Kocaeli City Hospital at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 8 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Zeynep Yasemin Tavşanoğlu, MD, DESAIC (+902622252700, zeynepyaseminyilmaz@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Postoperative Quality of Recovery Score (QoR-15T) (time frame: Postoperative Day 7 (or discharge day if earlier)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jun 2026.